This investigation aimed to enhance the solubility and bioavailability of the BCS class II poorly water-soluble drug Lornoxicam by solid dispersion (SD) techniques using Polaxomer 188 as a hydrophilic carrier. Solid dispersion of Lornoxicam was made through physical mixing (kneading method) and solvent Evaporation technique via different drug: carrier ratios. Prepared solid dispersion was characterized for solubility, drug content, percentage yield, and in vitro dissolution study. Solid-state characterization was performed by differential scanning calorimetry and Fourier-transform infrared spectroscopy. Lornoxicam's apparent solubility increased with an increasing level of carrier. A solid dispersion study revealed a better dissolution of l...
The solubility behavior of drug is one of most challenging aspect in formulation development. Thus a...
Background and purpose: Piroxicam is a non-steroidal anti- inflammatory drug that is characterized b...
In fact, it has been estimated that 40% of new chemical entities currently being discovered are poor...
This investigation aimed to enhance the solubility and bioavailability of the BCS class II poorly wa...
The main objective of the present work was to enhance the solubility and dissolution rate of poorly ...
Objective(s): Solid dispersion formulation is the most promising strategy to improve oral bioavailab...
The objective of this study was to improve the dissolution rate of a poor water soluble drug, piroxi...
The objective of this study was to improve the dissolution rate of a poor water soluble drug, piroxi...
The present study investigates the possibility of using poloxamers as solubility and dissolution rat...
Solid dispersions have been employed as a method to improve the dissolution rate and hence the bioav...
The solid dispersion technique is one of the most effective methods for improving the dissolution ra...
Introduction: The main objective of this study was preparation and characterization of solid dispers...
Objective: The aim of the work was to enhance the dissolution rate of rivaroxaban by preparing its s...
The purpose of this study was to investigate the efficacy of hydrophilic polymers in a solid dispers...
The objective of this study was to improve the dissolution rate of a hydrophobic non-steroidal anti-...
The solubility behavior of drug is one of most challenging aspect in formulation development. Thus a...
Background and purpose: Piroxicam is a non-steroidal anti- inflammatory drug that is characterized b...
In fact, it has been estimated that 40% of new chemical entities currently being discovered are poor...
This investigation aimed to enhance the solubility and bioavailability of the BCS class II poorly wa...
The main objective of the present work was to enhance the solubility and dissolution rate of poorly ...
Objective(s): Solid dispersion formulation is the most promising strategy to improve oral bioavailab...
The objective of this study was to improve the dissolution rate of a poor water soluble drug, piroxi...
The objective of this study was to improve the dissolution rate of a poor water soluble drug, piroxi...
The present study investigates the possibility of using poloxamers as solubility and dissolution rat...
Solid dispersions have been employed as a method to improve the dissolution rate and hence the bioav...
The solid dispersion technique is one of the most effective methods for improving the dissolution ra...
Introduction: The main objective of this study was preparation and characterization of solid dispers...
Objective: The aim of the work was to enhance the dissolution rate of rivaroxaban by preparing its s...
The purpose of this study was to investigate the efficacy of hydrophilic polymers in a solid dispers...
The objective of this study was to improve the dissolution rate of a hydrophobic non-steroidal anti-...
The solubility behavior of drug is one of most challenging aspect in formulation development. Thus a...
Background and purpose: Piroxicam is a non-steroidal anti- inflammatory drug that is characterized b...
In fact, it has been estimated that 40% of new chemical entities currently being discovered are poor...